These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3108874)

  • 1. Valpromide but not sodium hydrogen divalproate inhibits epoxide hydrolase in human liver.
    Pacifici GM; Rane A
    Pharmacol Toxicol; 1987 Mar; 60(3):237-8. PubMed ID: 3108874
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.
    Kerr BM; Rettie AE; Eddy AC; Loiseau P; Guyot M; Wilensky AJ; Levy RH
    Clin Pharmacol Ther; 1989 Jul; 46(1):82-93. PubMed ID: 2501059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valpromide inhibits human epoxide hydrolase.
    Pacifici GM; Franchi M; Bencini C; Rane A
    Br J Clin Pharmacol; 1986 Sep; 22(3):269-74. PubMed ID: 3094569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valpromide is a poor inhibitor of the cytosolic epoxide hydrolase.
    Pacifici GM; Temellini A; Giuliani L; Rane A; Thomas H; Oesch F
    Arch Toxicol; 1989; 63(2):157-9. PubMed ID: 2499297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid.
    Spiegelstein O; Kroetz DL; Levy RH; Yagen B; Hurst SI; Levi M; Haj-Yehia A; Bialer M
    Pharm Res; 2000 Feb; 17(2):216-21. PubMed ID: 10751038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saccharomyces cerevisiae: an alternative source for human microsomal liver enzymes and its use in drug interaction studies.
    Eugster HP; Sengstag C
    Toxicology; 1993 Oct; 82(1-3):61-73. PubMed ID: 8236282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsubstituted amides: new class of potent inhibitors of human microsomal epoxide hydrolase.
    Kerr BM; Levy RH
    Drug Metab Dispos; 1990; 18(4):540-2. PubMed ID: 1976080
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of epoxide hydrolase by anticonvulsants and risk of teratogenicity.
    Kerr BM; Levy RH
    Lancet; 1989 Mar; 1(8638):610-1. PubMed ID: 2564126
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo and in vitro correlation of microsomal epoxide hydrolase inhibition by progabide.
    Kroetz DL; Loiseau P; Guyot M; Levy RH
    Clin Pharmacol Ther; 1993 Nov; 54(5):485-97. PubMed ID: 8222491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae. Study of the valpromide-carbamazepine epoxide interaction.
    Eugster HP; Sengstag C; Hinnen A; Meyer UA; Würgler FE
    Biochem Pharmacol; 1991 Sep; 42(7):1367-72. PubMed ID: 1930259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of valproic acid and some analogues with microsomal epoxide hydrolase.
    Robbins DK; Wedlund PJ; Elsberg S; Oesch F; Thomas H
    Biochem Pharmacol; 1992 Feb; 43(4):775-83. PubMed ID: 1540232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine-valnoctamide interaction in epileptic patients: in vitro/in vivo correlation.
    Pisani F; Haj-Yehia A; Fazio A; Artesi C; Oteri G; Perucca E; Kroetz DL; Levy RH; Bialer M
    Epilepsia; 1993; 34(5):954-9. PubMed ID: 8104783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epoxide hydrolase in human fetal liver.
    Pacifici GM; Rane A
    Pharmacology; 1983; 26(5):241-8. PubMed ID: 6682981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of drug-drug interactions with carbamazepine-10,11-epoxide using a new in vitro assay for epoxide hydrolase inhibition.
    Rosa M; Bonnaillie P; Chanteux H
    Xenobiotica; 2016 Dec; 46(12):1076-1084. PubMed ID: 26936324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid.
    Spiegelstein O; Yagen B; Levy RH; Finnell RH; Bennett GD; Roeder M; Schurig V; Bialer M
    Pharm Res; 1999 Oct; 16(10):1582-8. PubMed ID: 10554101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of epoxide hydrolases and glutathione S-transferases by 2-, 3-, and 4-substituted derivatives of 4'-phenylchalcone and its oxide.
    Miyamoto T; Silva M; Hammock BD
    Arch Biochem Biophys; 1987 Apr; 254(1):203-13. PubMed ID: 3579298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of epoxide hydrolase from human, monkey, bovine, rabbit and murine liver by trans-3-phenylglycidols.
    Dietze EC; Casas J; Kuwano E; Hammock BD
    Comp Biochem Physiol B; 1993 Feb; 104(2):309-14. PubMed ID: 8462281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide.
    Pisani F; Fazio A; Oteri G; Spina E; Perucca E; Bertilsson L
    Br J Clin Pharmacol; 1988 May; 25(5):611-3. PubMed ID: 3136790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemical considerations on the inhibition of hepatic epoxide hydrolase by some pesticides and their epoxides.
    Cova D; Arnoldi A; Colombo R; Rossini L
    Toxicol Lett; 1986 Mar; 30(3):273-8. PubMed ID: 3705109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic microsomal cholesterol epoxide hydrolase: selective inhibition by detergents and separation from xenobiotic epoxide hydrolase.
    Watabe T; Ozawa N; Ishii H; Chiba K; Hiratsuka A
    Biochem Biophys Res Commun; 1986 Oct; 140(2):632-7. PubMed ID: 3778472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.